The story of Rosie, an eight-year-old Staffy cross Shar Pei from Sydney whose owner used AI and genomic sequencing to design a personalised mRNA cancer vaccine, captured global attention in early 2026. It is a genuinely remarkable case. It is also widely misread, and...
A research team at the Hong Kong University of Science and Technology has done something that was not supposed to be possible: they have flipped the fundamental logic of CRISPR gene editing. Published in Nature Biotechnology this month, the work by Professor Hsing...
Federal Budget 2026–27 — What It Means for Genomics and Precision Medicine The 2026–27 Federal Budget provides several positive signals for genomics and precision medicine in Australia, particularly across precision oncology, clinical trials, medicines access, digital...
InGeNA releases Position Statement on Genomics for Prevention and Population Screening InGeNA has released its new Position Statement on Genomics for Prevention and Population Screening, outlining the organisation’s support for the responsible, coordinated, and...
InGeNA welcomes our new partner the UTS Discipline of Genetic Counselling The Discipline of Genetic Counselling at the University of Technology Sydney plays a key role in educating the future genetic counselling workforce, preparing graduates to lead and shape the...
InGeNA welcomes our new member GenoCare GenoCare delivers innovative models of care that make genetic counselling and psychosocial support more accessible and scalable. By integrating clinical expertise with digital tools, GenoCare supports patients and healthcare...
